🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study to determine the safety and tolerability of pazopanib eye drops. Th...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-03-09
Trial ID
NCT01072214
The purpose of this study is to determine the safety and efficacy of differ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-01
Trial ID
NCT01134055
Treatments Being Tested
This is a two-period study to evaluate the effect of repeat oral dosing of ...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-04-04
Trial ID
NCT00659555
Treatments Being Tested
This is a two month study to allow continued treatment with pazopanib eye d...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-06-25
Trial ID
NCT00733304
Treatments Being Tested
The purpose of this 12 week, open-label study is to investigate the safety ...
Status
Terminated
Location
GSK Investigational Site
Start Date
2011-07-07
Trial ID
NCT01362348
Treatments Being Tested
This is a 28 day study to evaluate the pharmacodynamic effect of pazopanib ...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-03-05
Trial ID
NCT00612456
Treatments Being Tested
This is a two-part study to evaluate the safety, tolerability and pharmacok...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-03
Trial ID
NCT00463320
Treatments Being Tested